Spike residue 403 affects binding of coronavirus spikes to human ACE2

Nat Commun. 2021 Nov 25;12(1):6855. doi: 10.1038/s41467-021-27180-0.

Abstract

The bat sarbecovirus RaTG13 is a close relative of SARS-CoV-2, the cause of the COVID-19 pandemic. However, this bat virus was most likely unable to directly infect humans since its Spike (S) protein does not interact efficiently with the human ACE2 receptor. Here, we show that a single T403R mutation increases binding of RaTG13 S to human ACE2 and allows VSV pseudoparticle infection of human lung cells and intestinal organoids. Conversely, mutation of R403T in the SARS-CoV-2 S reduces pseudoparticle infection and viral replication. The T403R RaTG13 S is neutralized by sera from individuals vaccinated against COVID-19 indicating that vaccination might protect against future zoonoses. Our data suggest that a positively charged amino acid at position 403 in the S protein is critical for efficient utilization of human ACE2 by S proteins of bat coronaviruses. This finding could help to better predict the zoonotic potential of animal coronaviruses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2 / chemistry*
  • Animals
  • COVID-19 / virology
  • COVID-19 Vaccines
  • Caco-2 Cells
  • Cloning, Molecular
  • HEK293 Cells
  • Humans
  • Molecular Dynamics Simulation
  • Mutation
  • Protein Binding*
  • Replicon
  • SARS-CoV-2 / genetics*
  • SARS-CoV-2 / metabolism*
  • Species Specificity
  • Spike Glycoprotein, Coronavirus / chemistry*
  • Spike Glycoprotein, Coronavirus / genetics*
  • Stem Cells
  • Zoonoses

Substances

  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2